The full findings are scheduled to be presented May 16 at ACC.21. 

Low levels of residual mitral regurgitation after TEER can make a big impact on patient outcomes, researchers explained in a new analysis. 

The company also announced that two specialists with more than 25 years of industry experience have joined its leadership team. 

Researchers called for better guidelines that cover when clinicians should consider stopping anticoagulation therapy for patients with AFib. The risks of such medication, they observed, may often outweigh the benefits. 

In the past, Majmudar has also helped manage the Healthcare Transformation Lab at Massachusetts General Hospital and served as an associate professor at Harvard Medical School.

Researchers found that the procedure was associated with a high success rate and low mortality and stroke rates after 30 days.

“As much as 80% of a person’s health is determined by the social and economic conditions of their environment,” one specialist said. 

Can a disruptive technology from the past become the nemesis of calcified lesions in the future?

Some cardiologists vow to go out with their scrubs on, says St. Vincent Heart Center’s Mary Norine Walsh, MD, as she recalls an interventional cardiologist who declared that when he left the cath lab, he’d be gone for good, not doing “office work.”